ロード中...

A potential role of ruxolitinib in leukemia

INTRODUCTION: An increased understanding of cellular signaling pathways, like the JAK--STAT pathway, and the identification of the JAK2 V617F mutation in the classic Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), has generated great interest in the development of targeted JAK2...

詳細記述

保存先:
書誌詳細
主要な著者: Naqvi, Kiran, Verstovsek, Srdan, Kantarjian, Hagop, Ravandi, Farhad
フォーマット: Artigo
言語:Inglês
出版事項: 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4143907/
https://ncbi.nlm.nih.gov/pubmed/21635221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2011.589383
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!